Tilray, Inc. TLRY TLRY confirmed Tuesday it has been chosen by the Luxembourg Ministry of Health as a supplier of medical cannabis products for the country’s recently announced medical cannabis program.
The Canadian cannabis giant will supply Luxembourg with a variety of its pharmaceutical-grade and Good Manufacturing Practice-certified medical marijuana products. These will include extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.
These prescription-based medical cannabis products will be administered to qualifying patients in Luxembourg under the supervision of physicians.
“We believe that Tilray’s growth potential in the European Union represents a $1 billion opportunity, and today’s announcement affirms that we are turning potential into performance,” Irwin D. Simon, chairman and CEO stated. “With today’s validation from the Luxembourg Ministry of Health, Tilray now offers branded medical cannabis in 20 countries around the world -- a testament to our high standards and status as a trusted partner to patients in need. We’re proud to be building this unrivaled global platform and will continue to advocate for patient access in Europe and countries around the world.”
Currently, Tilray runs two state-of-the-art GMP-certified cannabis cultivation facilities in Europe located in Cantanhede, Portugal and Neumunster, Germany.
In addition, Tilray has established sales and distribution arrangements to supply medical cannabis through major pharmaceutical distribution channels, including CC Pharma, throughout Germany and the E.U., which will serve as a means to allowing patients to access Tilray's GMP-certified finished medical cannabis.
More recent news from Tilray:
Tilray Appoints Ex General Manager At Bacardi As New Pres Of Tilray Canada
Is Tilray Still A Bear Play Or Will Shorts Go Up In Smoke?
What Investors Need To Know On Heels Of Tilray's Q1 Earnings Release
Price Action
Tilray’s shares were trading 1.18% higher at $11.13 per share during Tuesday’s pre-market session.
Photo: Courtesy of Cedric Letsch on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!